Pharma

FDA rejects Vanda’s jet lag drug following yearslong dispute and ‘long-shot’ review Endpoints NewsVanda Pharmaceuticals (VNDA) Faces FDA Setback…

Interview Biotech company shares jumped 46% in $300m Hong Kong debut Biotech firm Insilico Medicine leverages artificial intelligence…

China’s new commercial insurance formulary looks to expand patient access to Alzheimer’s disease medicines from Eli Lilly and…

The year 2026 will be a year of tumult in American healthcare. Getty Images As December kicks off,…

The NICE threshold will rise to £25,000 to £35,000 for every quality adjusted life year. In return for…

Updated: CMS unveils negotiated prices for Ozempic, Wegovy and other drugs from second round of IRA talks Endpoints NewsU.S.…

The WHO wants pharma companies to consider tiered pricing (lower prices in lower-income countries) and voluntary licensing of…

Three years ago, generative AI was barely on anyone’s radar. Three months ago, circular deals were whispered about…

The boundaries between pharmaceuticals and nutraceuticals continue to blur. This year’s CPHI 2025 trade show highlighted innovations that…

The U.K. is locked in drug-pricing negotiations with the Trump administration and pharmaceutical firms about how much the…

BOSTON — The president of a leading addiction medicine group issued stark warnings on hardline Trump administration policies…

When I was a young medical student, I believed with all my heart that medicine was the highest…

FDA rejects Vanda’s jet lag drug following yearslong dispute and 'long-shot' review – Endpoints News